Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-12-07

Clinical Trial Update: Effectiveness of Adding Subcutaneous Long-Acting Detemir to Insulin Drip Therapy Compared With Standard Insulin Drip Therapy [NA]

View source ↗

Summary

A completed clinical trial comparing the addition of subcutaneous long-acting detemir to insulin drip therapy versus standard insulin drip in diabetes, with res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • detemir (insulin detemir)

Snippet

Sponsor: University of Colorado, Denver | Conditions: Diabetes | NA | Status: COMPLETED | Results posted: 2021-12-07